Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Hamdy

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2015
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomesZ Kote-Jarai, C Mikropoulos, D A Leongamornlert, et al.
British Journal of Cancer|August 25, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyJ W F Catto, M C Robinson, P C Albertsen, et al.
British Journal of Cancer|May 29, 2014
Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)E L Turner, C Metcalfe, J L Donovan, et al.
The New England Journal of Medicine|September 15, 2016
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate CancerJ L Donovan, F C Hamdy, J A Lane, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2015
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomesZ Kote-Jarai, C Mikropoulos, D A Leongamornlert, et al.
British Journal of Cancer|August 25, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyJ W F Catto, M C Robinson, P C Albertsen, et al.
British Journal of Cancer|May 29, 2014
Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)E L Turner, C Metcalfe, J L Donovan, et al.
The New England Journal of Medicine|September 15, 2016
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate CancerJ L Donovan, F C Hamdy, J A Lane, et al.
Pageof 11